Overbrook Management Corp’s IN8bio INAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,125
Closed -$5.6K 48
2025
Q1
$5.6K Hold
1,125
﹤0.01% 47
2024
Q4
$8.68K Hold
1,125
﹤0.01% 51
2024
Q3
$9.11K Hold
1,125
﹤0.01% 54
2024
Q2
$28.6K Hold
1,125
0.01% 56
2024
Q1
$39.8K Hold
1,125
0.01% 59
2023
Q4
$46.6K Hold
1,125
0.01% 65
2023
Q3
$35.1K Hold
1,125
0.01% 63
2023
Q2
$52K Buy
+1,125
New +$70.3K 0.01% 67

Other funds holding INAB

Overbrook Management Corp's INAB Position: Q2 2025 in Review

Overbrook Management Corp sold out of IN8bio (INAB) in Q2 2025, closing a stake of 1,125 shares — an estimated $5.6K sold.

Overbrook Management Corp first reported a position in INAB in Q2 2023 and held it in 8 quarters. The position peaked at $52K in Q2 2023. 12 funds tracked by Wall St. Rank hold INAB as of Q2 2025.

  • Overbrook Management Corp reported no remaining IN8bio position as of Q2 2025 after selling out during the quarter.
  • Overbrook Management Corp sold 1,125 IN8bio shares in Q2 2025, an estimated $5.6K.
  • Overbrook Management Corp first reported a position in IN8bio in Q2 2023 and held it in 8 quarters.
  • Overbrook Management Corp's IN8bio position peaked at $52K in Q2 2023.
  • 12 funds tracked by Wall St. Rank held IN8bio as of Q2 2025.

Based on Overbrook Management Corp's 13F filing for Q2 2025, filed 17 Jul 2025.